alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with desipramine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
| De Filippis, B; Laviola, G; Ricceri, L | 1 |
2 review(s) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and desipramine
| Article | Year |
|---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
Mouse models of Rett syndrome: from behavioural phenotyping to preclinical evaluation of new therapeutic approaches.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Brain; Desipramine; Disease Models, Animal; Drug Evaluation, Preclinical; Epigenesis, Genetic; Female; Genetic Therapy; Humans; Methyl-CpG-Binding Protein 2; Mice; Mice, Transgenic; Phenotype; Psychotropic Drugs; Rett Syndrome | 2008 |